lactic acid has been researched along with Parkinson Disease, Secondary in 5 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glavina, T | 1 |
| Mrass, D | 1 |
| Dodig, T | 1 |
| Glavina, G | 1 |
| Pranić, S | 1 |
| Uglešić, B | 1 |
| Mendhekar, DN | 1 |
| Benuiwal, RP | 1 |
| Puri, V | 1 |
| McRae, A | 1 |
| Dahlström, A | 1 |
| Jenkins, BG | 1 |
| Brouillet, E | 1 |
| Chen, YC | 1 |
| Storey, E | 1 |
| Schulz, JB | 1 |
| Kirschner, P | 1 |
| Beal, MF | 1 |
| Rosen, BR | 1 |
| Sundström, E | 1 |
| Samuelsson, EB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Blood Lactate Levels in Patients Treated With Typical or Atypical Antipsychotics[NCT01139463] | 60 participants (Actual) | Observational | 2008-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for lactic acid and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Blood lactate levels in patients receiving first- or second- generation antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dopamine Antagonists; Drug Monitoring; Haloperidol; Hu | 2011 |
4 other studies available for lactic acid and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Parkinsonism and elevated lactic acid with sertraline.
Topics: Basal Ganglia; Depressive Disorder, Major; Female; Humans; Lactic Acid; Magnetic Resonance Imaging; | 2005 |
Transmitter-loaded polymeric microspheres induce regrowth of dopaminergic nerve terminals in striata of rats with 6-OH-DA induced parkinsonism.
Topics: Animals; Apomorphine; Capsules; Dopamine; Immunohistochemistry; Lactic Acid; Male; Microspheres; Neo | 1994 |
Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging.
Topics: Aging; Animals; Aspartic Acid; Electron Transport Complex II; Energy Metabolism; Huntington Disease; | 1996 |
Comparison of key steps in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in rodents.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Brain; Dopamine; | 1997 |